HighTide Therapeutics, Inc. (HKG:2511)
Hong Kong · Delayed Price · Currency is HKD 2.920
-0.130 (-4.26%)
At close: Mar 27, 2026
HighTide Therapeutics Employees
HighTide Therapeutics had 57 employees as of June 30, 2025. The number of employees decreased by 13 or -18.57% since the number was reported on December 31, 2024.
Employees
57
Change
-13
Growth
-18.57%
Revenue / Employee
n/a
Profits / Employee
-4.78M HKD
Market Cap
1.67B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 57 | -13 | -18.57% |
| Dec 31, 2024 | 70 | 4 | 6.06% |
| Dec 31, 2023 | 66 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1,629 |
| Frontage Holdings | 1,540 |
| Mabpharm | 383 |
| Cutia Therapeutics | 298 |
| Zhaoke Ophthalmology | 270 |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 195 |
| Immunotech Biopharm | 173 |
| Transcenta Holding | 171 |